Stage IIA Prostate Cancer Recruiting Phase 1 / 2 Trials for Degarelix (DB06699)

IndicationStatusPhase
DBCOND0028878 (Stage IIA Prostate Cancer)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02346253High-Dose Brachytherapy in Treating Patients With Prostate CancerTreatment